Jan
17
Constellation Pharmaceuticals and Genentech Enter Broad Epigenetics Drug Discovery Collaboration
Posted in Constellation in the News, NewsroomCAMBRIDGE, Mass. – January 17, 2012 – Constellation Pharmaceuticals, Inc., today announced that it has entered into a major strategic agreement with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), to launch a broad collaboration based on the science of epigenetics and chromatin biology to discover and develop innovative treatments for [...]